This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
zacks-consensus-estimate: Archive
Wall Street Analysts Think Block (XYZ) Could Surge 37.37%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 37.4% in Block (XYZ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
XYZNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Babcock & Wilcox (BW) Could Surge 44.39%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Babcock & Wilcox (BW) points to a 44.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
BWNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Why Casey's General Stores (CASY) is a Top Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
CASYNegative Net Change
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
Why JPMorgan Chase & Co. (JPM) is a Top Stock for the Long-Term
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
JPMNegative Net Change
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
LENZ Therapeutics, Inc. (LENZ) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
LENZ Therapeutics, Inc. (LENZ) delivered earnings and revenue surprises of -28.18% and -66.75%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
LENZNegative Net Change NVCRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Concentrix Corporation (CNXC) Lags Q1 Earnings Estimates
by Zacks Equity Research
Concentrix (CNXC) delivered earnings and revenue surprises of -1.14% and +0.51%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?
CNXCNegative Net Change MRSHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Core & Main (CNM) Q4 Earnings Top Estimates
by Zacks Equity Research
Core & Main (CNM) delivered earnings and revenue surprises of +8.33% and -0.42%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?
CNMPositive Net Change EPACPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates
by Zacks Equity Research
Sanara MedTech (SMTI) delivered earnings and revenue surprises of -63.64% and +0.53%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
SMTINegative Net Change ABTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Adherex Technologies (FENC) delivered earnings and revenue surprises of -540.00% and -7.94%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
FENCNegative Net Change SGMONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Smithfield Foods, Inc. (SFD) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Smithfield Foods, Inc. (SFD) delivered earnings and revenue surprises of +25.76% and +0.96%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
SFDNegative Net Change PRPLPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank